It is not clear if tumor-suppressive effects can still be achieved through direct administration of piR-YBX1 to mice, we used a chemically modified piR-YBX1 mimic called agopiR-YBX1 which can be existed in vivo conditions to detect its function [40]. The gene discussed is PIR; the disease is neoplasm.